Exercise training improves recovery in patients with COPD after an acute exacerbation  by Kirsten, D.K. et al.
RESPIRATORY MEDICINE (1998) 92, 1191-1198 
Exercise training improves recovery in patients with 
COPD after an acute exacerbation”+ 
D. K. KIRSTEN, C. TAUBE, B. LEHNIGK, R. A. J~RRES AND H. MAGNUSSEN 
Krankenhaus Grosshansdovf, Zentvum fiir Pneumologie und Thovaxchirwgie, LVA Freie und 
Hansestadt Hamburg, Germany 
Clinical experience suggests that exercise is beneficial for recovery after an acute exacerbation in patients with severe 
chronic obstructive pulmonary disease (COPD). The aim of this study was to quantify the clinical benefit of exercise 
in these patients. 
Twenty-nine inpatients were randomly assigned to a training group (n= 1.5, FEV, 34% pred) or a control group 
(n=14, FEV, 38% pred). On ten consecutive days, patients in the training group performed a 6-min treadmill 
walking test and, in addition, five walking sessions per day at 275% of the respective treadmill walking distance. 
Patients in the control group performed only treadmill walking tests on days 1, 5, and 10. To directly compare the 
possible benefit of exercise training all patients had an exercise test on day 11 at the same work load as on day 1. 
In the training group, 6-min walking distance increased from 237 to 420 m, in the control group from 230 to 255 m 
over the 10 day period which was significantly different (P<O.OOOl). Minute ventilation and oxygen uptake increased 
significantly (PiO.05) in the training but not in the control group. When comparing exercise tests on days 1 and 11, 
minute ventilation, oxygen uptake, PaCO,, lactic acid concentration, and Borg scale were significantly reduced to 
achieve the same work load (P<O.Ol) only in the training group. Intrathoracic gas volume and residual volume 
decreased, and FEV, and vital capacity increased in the training (P~0.05) but not in the control group. 
Our data demonstrate that exercise training significantly improves the exercise capacity in patients with severe 
COPD after an acute exacerbation of their disease. 
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Introduction 
Exercise training is an essential part of pulmonary rehabili- 
tation programmes in patients with chronic obstructive 
pulmonary disease (COPD) (1). Studies have demonstrated 
beneficial effects of exercise training, such as improvement 
in exercise tolerance, reduction of exertional dyspnea, 
improvement in quality of life indices, and amelioration of 
ventilatory parameters (2-8). Most of these studies involved 
training programmes over several weeks or months. There- 
fore, long-term training appears to be effective in patients 
with COPD in a stable condition and with moderate degree 
of their disease. 
In addition, clinical experience suggests that exercise can 
support the recovery after an acute exacerbation in patients 
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with unstable severe chronic obstructive pulmonary disease 
(COPD). This practice, however, is largely based on casual 
observations and has not been studied in detail. Therefore, 
the aim of our study was to evaluate the clinical benefit of 
short-term exercise in patients with severe COPD after an 
acute exacerbation. 
Materials and Methods 
PATIENTS 
We studied patients with severe COPD within a referral 
hospital after an acute exacerbation of their disease. The 
diagnosis and treatment of COPD followed international 
guidelines (1,9). The study was started 6-8 days after 
admission when patients had improved and were able to 
participate in the protocol. Thirty-one patients were 
included. At the beginning of the study period, patients 
were randomly assigned either to a training or a control 
group. Two patients had to be excluded during the study 
due to acute bronchitis or the development of ankle 
edema, respectively. Therefore, 29 patients completed the 
study. All patients showed a forced expiratory volume in 
1 s (FEV,) below 60% of their mean predicted values (10). 
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TABLE 1. Baseline characteristics of patients with severe COPD 
Training Control 
group group 
?I 
Gender 
Age 
Height 
Weight 
BDI score* 
Systemic steroids 
Day 0 
Day 11 
Theophylline serum level 
HBCO 
Long-term oxygen therapy 
15 14 
m/f 1213 14/o 
years 62.3 * 9.1 65.6 Z!Z 11.8 
ic; 
174.4 * 8.1 174.3 Z!= 6.6 
70.7 * 15.1 71.9 zt 15.1 
4.7 + 2.2 4.0 f 1.6 
mg 40.3 zt 15.6 40.7 f 12.5 
w 21.7 & 7.7 19.8 & 6.5 
mg/l 9.8 zk 6.0 12.0 zk 2.4 
mg % 1.50 * 0.44 1.88 •t 0.76 
yh 5/10 4110 
Mean values and standard deviations are given. 
*Baseline dyspnea index. 
They did not complain of lung diseases other than COPD; 
patients with unstable cardiac disease, car pulmonale 
decompensation or other diseases, which prohibited the 
participation in the exercise programme, were not 
admitted to the study. Twenty-six of the patients took 
theophylline, 29 inhaled corticosteroids and 28 systemic 
corticosteroids, owing to their acute exacerbation which 
led to hospital admission. All patients inhaled ,& 
adrenoceptor agonists and anticholinergic regularly and 
additionally on demand. Medication was continued 
through the whole period of training and did not differ 
between both groups. Patients were ex-smokers and 
smoking habits were controlled for by measurement of 
HBCO levels (Table 1). 
STUDY PROTOCOL 
Patients started the training immediately when they were 
stable enough to participate in the training programme, 
which was decided on clinical status and blood gas values. 
However, they were unstable in the sense that they were still 
in the process of gradual improvement as reflected in 
tapering off steroid doses (Table 1). 
All patients participated in the baseline testing on study 
day 0. Both the training and the control group performed 
6-min treadmill walking tests on study days 1, 5, and 10. 
Furthermore, on day 11, all patients performed a 6-min 
walking test at the same work load and average pace, 
respectively, which they had achieved on day 1, and the 
tests, which had been done on study day 0, were repeated. 
Whereas patients in the control group did not perform 
regular exercise during study days 1 to 10, patients in the 
training group performed a 6-min treadmill walking test on 
each day and, in addition, five walking sessions per day 
(Fig. 1). 
LUNG FUNCTION TESTING AND BLOOD GAS 
ANALYSIS 
On day 0 and day 11, after the treadmill test, FEV,, vital 
capacity (VC), airway resistance (RAW), intrathoracic gas 
volume (ITGV), residual volume (RV), inspiratory capacity 
(IC), and expiratory reserve volume (ERV) were measured 
in a body plethysmograph (Materlab, Jaeger, Wiirzburg, 
Germany). The transfer factor for carbon monoxide 
(7’1C0) and the transfer factor divided by alveolar volume 
(Krogh factor, ~CO/~A) were determined by the single 
breath method. 1zCO was corrected for the concentration 
of hemoglobin (11). Predicted values were calculated 
according to the guidelines of the ERS (10). Maximal 
inspiratory pressure after 0.1 s (Po.imax) was measured in 
a suitably equipped body plethysmograph (Ganzhorn, 
Miinnerstadt, Germany) during a maximal inspiratory 
maneuver from residual volume against a closed shutter. 
PO-lXlZ+X was defined as the pressure measured after 100 ms, 
the best of six trials being taken for analysis. Blood gas 
analysis was achieved from the hyperemic ear lobe to yield 
pH, PaCO,, and PaO, (Blood gas analyzer model 278, Ciba 
Corning, Fernwald, Germany). Quality of life and overall 
dyspnea were assessed using a German translation (12,13) 
of the Baseline (BDI) Dyspnea Index (14). 
TREADMILL EXERCISE TESTING 
Exercise performance was assessed as the 6-min walking 
distance in a self-paced treadmill walking test (15) on 
a horizontal treadmill (LE 2000, Jaeger, Wiirzburg, 
Germany). The treadmill was equipped with a speed control 
module for the patient’s use. At the beginning of each 
walking test, patients were instructed to walk as far as 
possible in 6 min; no further encouragement was given 
during the walk. Prior to the training, on day 0, patients 
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FIG. 1. Study protocol. 
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had performed one walk to become familiar with the 
procedure. 
MEASUREMENTS PERFORMED DURING 
TREADMILL EXERCISE TESTING 
In the treadmill walking tests, patients breathed ambient air 
through a mouthpiece, with a noseclip in place. Expired air 
was analyzed for flow rate, O,, and CO, concentration. 
Minute ventilation ( VE), oxygen uptake (VO,), and carbon 
dioxide output (VCO,) were determined as half-minute 
average values (Oxycon, Jaeger, Wiirzburg, Germany). 
From these parameters, oxygen uptake per body weight 
(VO,/kg), oxygen pulse (VO,/HR) were computed. Heart 
rate (HR) and oxygen saturation were measured by a pulse 
oximeter at the ear lobe (Biox 111, Ohmeda, U.S.A.). For 
analysis, mean values over the 6-min walking period were 
taken. In each of the four treadmill exercise tests, venous 
blood samples were drawn at the beginning during resting 
ventilation and within the last minute of the exercise. 
Aliquots (20~1) of each sample were mixed with iced 
perchlorate solution (200 ~1) and centrifuged, the super- 
natant being analyzed for lactic acid concentration (16). 
Blood gases were measured from the hyperemic ear lobe 
during the last minute of exercise test. The alveolo-arterial 
partial pressure difference of oxygen (PA-a0,) was esti- 
mated using the alveolar gas formula for calculation of 
alveolar oxygen partial pressure (PAOJ. Exertional breath- 
lessness was assessed by the categorical scale according to 
Borg (17). In addition, changes in overall dyspnea and 
quality of life were determined by the Transition Dyspnea 
Index (TDI) (12-14). 
EXERCISE IN THE TRAINING GROUP 
The additional exercise, which the patients in the training 
group performed, comprised five self-controlled walking 
sessions per day in the corridor. Patients were instructed to 
achieve at least 7.5% of the distance which they had shown 
in the treadmill walking test on the respective day but 
without time limit. The training was supervised by nurses 
and one of the investigators (C.T.). 
DATA ANALYSIS 
Throughout the study, parametric tests were used for 
parameters which were normally distributed and non- 
parametric tests for other parameters. For lung function, 
blood gas, exercise parameters, and Borg scale, arithmetic 
mean values and standard deviations of mean (SEM) were 
computed. Baseline characteristics obtained on days 0 and 1 
were compared between the training and control group by 
the unpaired t-test or the Mann-Whitney U-test. In both 
groups, paired t-tests or Wilcoxon matched-pairs signed- 
rank tests were employed to compare values obtained on 
different study days. TDI scores were analyzed by the sign 
test versus a median value of zero. 
Comparison between groups was achieved by repeated 
measures analysis of variance for the values obtained 
on study days 1, 5, and 10. This type of analysis 
revealed differences between groups during the training 
period mainly via the interaction term. Furthermore, to 
analyze specifically at the single time points, the per cent 
changes on days 5, 10, and 11 were compared between 
groups by the unpaired t-test or the Mann-Whitney 
U-test. 
1194 D. K. KIRSTEN ET AL. 
TABLE 2. Mean values and standard deviations of mean for exercise parameters 
Training group Control group 
Day 1 Day 10 Day 11 Day 1 Day 10 Day 11 
Walking distance m 237 =k 28 42Oi42j 
Borg scale 3.9 i 0.2 4.4 It 0.3 
T/E llmin 29.9 zt 2.1 35.0f2.7$ 
Breathing frequency lmin 24.5 f 1.5 25.0 i 1.0 
Heart rate lmin 112.1 zt 2.0 114.3 =Iz 4.6 
VO,/kg ml/(min* kg - ‘) 12.7 * 0.8 15.5 zlz 0.Q 
VO,/HR ml/beat 8.0 + 0.8 9.7 f 0.91 
PaO, exercise11 mmHg 59.2 f 2.2 59.3 ic2.1 
PaCO, exercise11 mmHg 41.4 f 1.9 41.6 $2.0 
PA-a02 mmHg 41.5 +z 3.1 41.4 IL 3.4 
Lactic acid mmolll 1.75 & 0.19 1.8Oi 0.25 
-§ 
2.7 f 0.2" 
25.6 zk 1.5" 
21.8 + 1.0” 
102.4 +z 3.0* 
10.6 f 0.6* 
7.4 + 0.6 
63.2+ 1.7" 
37.9 * 1.9" 
39.61t 2.5 
0.86& 0.08* 
23Ozk23 
4.5 Ito. 
32.9+ 2.8 
26.0 + 1.3 
107.9 5 3.3 
13.4* 1.0 
9.0% 0.9 
61.8 h2.2 
42.7 tt 1.8 
39.252.4 
1~70~0~31 
255&27$ 
4.4 +0.3-f 
33.3 5 3.0 
26.4 z!r 1.6 
110.4* 3.7 1 
13.9 * 1.0 
9.2+ 0.9 
59.3 h2.01 
42.2 I!= 1.8 
41.1 zt2.2 
1.69 ztO.24 
-§ 
4.2 =t 0.4 
30.3 zt 2.6 
24.4 zt 1.8 
107.61t 3.5 
12.8 50.8 
8.6 ztO.8 
60.4zk2.2 
41.9 * 1.7 
38.3 1L2.5 
1.55 * 0.21 
*Significantly (PcO.05) different from values on day 1; tsignificantly (PcO.05) different from values on day 5; Ssignificantly 
different (PcO.05) different from values on day 1 and 5; swalking distance identical to that on day 1; llmeasured during the 
last minute of exercise test. 
TABLE 3. Mean values and standard errors of mean for lung function parameters before and after the 
training period 
Training group Control group 
Day 0 Day 11 Day 0 Day 11 
vc 
TLC 
ITGV 
RV 
FEV, 
IC 
RAW 
PO.l~ZiX 
TLCO 
PaO, at rest 
PaCO, at rest 
%predicted 
%predicted 
%predicted 
%predicted 
%predicted 
Liter 
kPalL s - ’ 
kPa 
%predicted 
mmHg 
mmHg 
80.8 * 3.3 
124.7 i. 3.8 
182.6xt 8.2 
210.2% 15.1 
34.3 * 2.6 
2.041tO.66 
6.8 + 0.6 
2.77 xt 0.39 
76.8 Z!T 6.7 
65.8 f 2.1 
40.2+ 1.8 
88.4+4.5* 
122.3 I!Z 3.6 
168.1It 6.6"r 
188.4& 12.8* 
38.21k 3.1" 
2.38 =k 0.95" 
6.3 zk 0.6 
3.27 f 0.46t 
75.4& 6.2 
66.2 zk 1.8 
39.2zt 1.7 
70.7& 5.5 
123.3 + 5.5 
179.8 =k 12.6 
220.1 zk 20.3 
37.7 f 3.4 
2.07 *0.79 
6.6iO.6 
2.21 kO.39 
73.9 zt 6.4 
64.3 + 2.1 
40.4zt 1.6 
74.3 zt4.0 
122.2zt 6.4 
176.1 + 13.9 
209.8 zk 20.1 
38.1 f 3.0 
2.04 f 0.79 
5.4 f. 0.5 
2.65 ztO.41 
74.7 f 6.4 
65.1 k2.2 
40.6 + 1.7 
Level of statistical significance for comparison of day 0 and 11: P<O45*, P<@Olt. 
For correlation analysis, Spearman’s rank correlations 
coefficients were used. All tests were performed two- 
tailed. The level of statistical significance was assumed at 
P=O.O5. 
The maximum improvements in walking distance in 
patients of the control group were 79 m and 27%, respect- 
ively (see Results). Choosing about twice these maximum 
changes, we selected cut-off values of 140 m and 60% in 
order to define responders and non-responders in terms of 
absolute or relative increase in walking distance. 
shown in Table 1 and baseline values are given in Table 2 
(day 1) and 3 (day 0). Both groups did not differ signifi- 
cantly with respect to their physical characteristics and 
medical treatment. Similarly, lung function parameters, 
blood gas values, BDI scores, 6-min walking distance, 
spiroergometric data, and Borg scale showed no significant 
differences (Tables l-3). 
TRAINING GROUP 
Results 
Comparison of Values &wing Training on Days 1, 5, 
and 10 
Fifteen patients were assigned to the training group and 14 
patients to the control group. Patients’ characteristics are 
In the training group, the 6-min walking distance increased 
from day 1 to day 5, day 1 to day 10, and day 5 to day 10 
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FIG. 2. Mean values and SEM of per cent changes in minute ventilation ( VE), oxygen uptake (VO,/kg), oxygen pulse (VO,/ 
HR), arterial blood gas pressure of carbon dioxide (PaCO,), Borg scale, and lactic acid concentration in venous blood 
samples during treadmill exercise on day 10. These values refer to the maximum gain in walking distance achieved in 
the training group ) or control group (0) as compared to baseline values on day 1. *Indicates significant (PcO.05) 
difference from day 1. 
(P40.0001 each) (Table 2). Among the 15 patients, 11 
patients demonstrated an improvement in walking distance 
by at least 60% and 11 patients by at least 140 m; the 
maximum improvements were 189% and 372 m, and the 
minimum improvements 24% and 21 m, respectively. Fur- 
thermore, minute ventilation, VO,/kg, and vO,/HR were 
increased on day 10 compared to day 1 and on day 10 
compared to day 5 (PcO.05 each) (Fig. 2). TDI scores were 
higher than zero on day 5 and day 10 (P10.0002 each). 
Other parameters did not change significantly. 
Comparison at the Same Work Load on Day 1 and 
Day 11 
We performed an additional exercise test on day 11 at the 
same work load achieved on day 1. This comparison 
revealed that on day 11, minute ventilation (P=O.O006), 
breathing frequency (BF) (P=O.OlO), heart rate (P=O.OOS), 
I’OJkg (P=O.O004), PaCO, during exercise (p = 0.0002), 
lactic acid concentration (P=O.O006), and the ratings on the 
Borg scale (P=O.O02) were reduced (Table 2, Fig. 3). PaO, 
during exercise was increased (P=O.O16). Other exercise 
parameters did not show significant changes. 
Lung function Parameters on Day 11 and Day 0 
On day 11, ITGV (P=O.O03) and RV (P=O.O17) were 
significantly reduced compared to day 0, whereas Po.,max 
(P=O:OO9), VC (P=O.O46), IC (P=O.O3), and FEV, 
(PzO.03) were raised (Table 3). 
COtiTROL GROUP 
In the control group, 6-min walking distance raised signifi- 
cantly from day 1 to day 10 (P=O.O035) and from day 5 to 
day 10 (P=O.O017) (Table 2). Among the 14 patients, 12 
patients showed an increase in walking distance in day 10 
vs. day 1 by less than 20%, 12 patients by less than 60 m, 
and 9 patients by less than 30 m. The maximum increases 
were 27% and 79 m, respectively. PaO, during exercise was 
reduced on day 10 compared to day 1 and 5 (P<O.O5 each) 
and TDI scores were greater than zero on day 5 and day 10 
(PcO.002 each). There were no other statically significant 
changes in exercise parameters (Table 2) on days 5, 10, and 
11 compared to day 1, or in lung function parameters on 
day 11 compared to day 0 (Table 3). 
TRAINING GROUP VERSUS CONTROL GROUP 
Comparison of values on days 1, 5, and 10 
The increase in 6-min walking distance on day 5 and day 10 
compared to day 1 was significantly larger in the training 
group than in the control group (P<O.OOOl each). Repeated 
measures analysis of variance showed that during the 
training period (day 1 to day 10) the course of minute 
ventilation, VOJkg, VO,/HR, and Borg Scale was signifi- 
cantly different between groups (PcO.05 each) (Fig. 2). 
Specifically, on day 10, the per cent increases in minute 
ventilation and VOJkg were higher in the training than in 
the control group (PcO.05 each). TDI scores were larger on 
day 5 and day 10 in the training than in the control group 
(PcO.05 each). 
Comparison of Values on Day 11 
On day 11, per cent reductions in lactic acid concentration 
(P=O.O04), PaCO, during exercise (P=O.O17), VO,/kg, and 
Borg scale (P=O.O035) as well as per cent increasesin PaO, 
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FIG. 3. Mean values and SEM of per cent changes of exercise parameters (cf. Fig. 1) on day 11 compared to day 1. Note 
that these values were obtained at the same individual walking distance as on day 1. Training group; 0, control group. 
*Indicates significant (PcO.05) difference from day 1. 
during exercise (P=O.O03) were significantly larger in the 
training group compared to the control group (Table 2, 
Fig. 3). 
The percent changes in lung function parameters did not 
differ between the training group and the control group. 
In addition, we determined by discriminant analysis the 
relative strength of the parameters in separating both 
groups according to their percent changes achieved on day 
11. The rank order was: lactic acid, Borg scale and PaCO,. 
When these three parameters were included in the analysis, 
other parameters did not add further information. 
CORRELATION ANALYSIS IN THE TRAINING 
GROUP 
Within the training group, the absolute (~~0.87) and the 
per cent increases (r=0.90) in 6-min walking distance 
achieved on days 5 and 10 relative to day 1 were (P<O.OOOl) 
correlated with each other. There were no significant corre- 
lations between the per cent increase in walking distance 
on day 10 and the corresponding changes in ventilatory 
parameters, blood gases, or Borg scale. 
Discussion 
This study demonstrates the effectiveness of a short-term 
exercise training programme during recovery from an acute 
exacerbation in patients with severe COPD. Compared to 
control patients, walking distance and maximum minute 
ventilation were significantly improved after the short- term 
exercise programme. The benefits became most obvious 
when ventilation rate, oxygen uptake, Borg scale, and lactic 
acid were compared between exercise tests performed at the 
same work load. 
Long-term exercise training is a well-established part 
of pulmonary rehabilitation programmes in patients with 
stable or moderate COPD (7,8,18,19). It has not been 
studied, however, to which extent a short-term training 
protocol supports patient’s recovery after an acute exacer- 
bation. This is surprising because in clinical practice 
patients are often encouraged by physicians to exercise. 
Indeed, our study provides evidence that a controlled 
short-term training markedly improves recovery. 
As patients were studied after admission to the hospital it 
was likely that the effects of exercise were superposed onto 
the effects of continued medical care including standard 
physical therapy. We accounted for this by inclusion of a 
control group without exercise. Thus, the control group was 
an essential part of our study. Since the improvements were 
much larger in the training than in the control group, our 
results suggest that the training protocol which was used 
incorporated more intense exercise than is usual in clinical 
practice. 
The 6-min walking test is a suitable measure of exercise 
capacity in patients with COPD (12,13,20,21). Indeed, 
exercise capacity in terms of 6-min walking distance showed 
the most striking results in our study which may have been 
favoured by the fact that walking distance was chosen as 
outcome measure. It is known that the 6-min walking 
distance can be influenced by learning and motivation. 
Learning, which has been described for stable COPD, could 
account for an improvement of about 33% (21) and changes 
of more than 54 m have been stated to be clinically relevant 
(20). All but one patient in the training group outran both 
values at the end of the 10 days period. Therefore, it is 
unlikely that the increases in 6-min walking distance owed 
to learning. The maximum improvements demonstrated by 
the patients in the control group were 79 m and 27%. 
Therefore, we defined a positive response to the exercise to 
be about twice these values, i.e. larger than 140 m or 60%, 
and found 13 of the 15 patients in the training group to be 
responders. One patient showed an increase by at least 
140 m as well as 60%; this patient was among those 
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demonstrating low baseline values (113 m). Patients who 
showed an increase of less than 140 m showed a lower than 
average baseline walking distance, and patients who 
showed an increase of less than 60% showed a higher than 
average baseline value. These results suggest that a suitable 
definition of responders should require an absolute change 
and/or a relative change in walking distance. 
It has been suggested that the ability to achieve the 
anaerobic threshold predicts larger improvements after 
training (18). In our study, however, the anaerobic 
threshold was not reached in the majority of tests, similarly 
to previous data (7,22,23). Probably, the mechanism 
responsible for the positive effects of exercise was the 
combination of muscle training below the anaerobic 
threshold as indicated by lactic acid concentrations, 
reduced dyspnea as indicated by Borg scale, improved lung 
function, and increased motivation (24) and coordination. 
Lung function parameters showed significant improve- 
ments after training; intrathoracic gas volume and residual 
volume were reduced and FEV, was increased. However, 
changes were small and their clinical significance remains 
questionable. In addition, TDI scores improved in the 
training group, which indicates a gain in quality of life 
through the training protocol. There were no correlations 
between changes in lung volumes, FEV,, and exercise 
capacity. It may be noted that, according to a previous 
study (13), exercise capacity, lung hyperinflation, and air- 
way obstruction represent three independent factors in 
patients with stable severe COPD. 
The increase in exercise capacity on day 10 was associ- 
ated with increases in oxygen uptake and minute ventila- 
tion. Similar findings have been reported after short-term 
training in patients with stable COPD (25) which was 
accompanied by an improvement in mid-expiratory and 
peak flow rates. The effect of the training program was 
most obvious when comparing two exercise tests performed 
at the same work load before and after training. After 
training, significant reductions in lactic acid concentration, 
carbon dioxide arterial pressure and oxygen uptake as well 
as Borg scale and an increase in arterial oxygen pressure 
occurred, indicating improved metabolic performance at 
lower exercise levels. The reduction in Borg scale could be 
related to desensitization of dyspnea (26), the improved 
respiratory efficiency to the decrease in intrathoracic gas 
volume (19) and residual volume and the increase in FEV,. 
In summary, our data demonstrate that a controlled 
short-term exercise training program adds significantly to 
the recovery after an acute exacerbation in patients with 
severe COPD. 
References 
1. European Respiratory Society. ERS consensus state- 
ment: optimal assessment and management of chronic 
obstructive pulmonary disease (COPD). Eur Respir J 
1995; 8: 1398-1420. 
2. Patessio A, Carone M, Ioli F, Donner CF. Ventilatory 
and metabolic changes as a result of exercise training in 
COPD patients. Chest 1992; lOl(Supp1 5): 274-278. 
3. O’Donnell D, Webb K, McGuire M. Older patients 
with COPD: benefits of exercise training. Geriatrics 
1993; 48: 59-66. 
4. Niederman MS, Henderson Clemente P, Fein AM, 
Feinsilver SH, Robinson DA, Ilowite JS, Berstein MG. 
Benefits of a multidisciplinary pulmonary rehabilita- 
tion program. Chest 1991; 99: 799-804. 
5. Wanke Th, Formanek D, Lahrmann H, Brath H, Wild 
M, Wagner Ch, Zwick G. Effects of combined inspira- 
tory muscle and cycle ergometer training on exercise 
performance in patients with COPD. Eur Respir J 1994; 
7: 2205-22 11. 
6. ZuWallack R, Pate1 K, Rardon JZ, Clark III BA, 
Normandin EA. Predictors of improvement in the 
12-minute walking distance following a six-week out- 
patient pulmonary rehabilitation program. Chest 1991; 
99: 805-809. 
7. O’Donnell DE, McGuire M, Samis L, Webb KA. The 
impact of exercise reconditioning on breathlessness in 
severe chronic airflow limitation. Am J Respir Crit Care 
Med 1995; 152: 2005-2013. 
8. Vale F, Reardon JZ, ZuWallack RL. The long-term 
benefits of outpatient pulmonary rehabilitation on 
exercise endurance and quality of life. Chest 1993; 103: 
4249. 
9. American Thoracic Society. Standards for the diagno- 
sis and care of patients with chronic obstructive pul- 
monary disease (COPD) and asthma. Am J Respir Cvit 
Care Med 1995; 152: 77-120. 
10. Quanjer PhH. Standardized lung function testing. Eur 
Respir J 1993; 16 (Suppl 6): 5-100. 
11. American Thoracic Society. Single breath carbon 
monoxide diffusing capacity, recommendations for a 
standard technique. Am Rev Respir Dis 1987; 136: 
1299-1307. 
12. Kirsten D, Wegner R, Jarres R, Magnussen H. Effects 
of theophylline therapy withdrawal in severe chronic 
obstructive pulmonary disease. Chest 1993; 104: 
1101-l 107. 
13. Wegner RE, Jijrres RA, Kirsten DK, Magnussen H. 
Factor analysis of exercise capacity, dyspnoea ratings 
and lung function in patients with severe COPD. Eur 
Respir J 1994; 7: 725-729. 
14. Mahler DA, Rosiello RA, Harver A, Lentine T, 
McGovern JF, Daubenspeck JA. Comparison of clini- 
cal dyspnea ratings and psychophysical measurements 
of respiratory sensations on obstructive airway disease. 
Am Rev Respir Dis 1987; 135: 1229-1233. 
15. Beaumont A, Crockroft AM, Guz A. A self paced 
treadmill walking test for breathless patients. Thorax 
1987; 42: 773-778. 
16. Bergmeyer HU, No11 F. Me&de der Enzymatischen 
Analyse, 3rd edn, 1974, Vol. II, p. 1521. 
17. Borg G. Psychophysical basis of perceived exertion. 
Med Sci Sports Exert 1982; 14: 377-381. 
18. Casburi R, Patessio A. Iolio F, Zanaboni S, Donner 
CF, Wassermann K. Reductions in exercise lactic 
acidosis and ventilation as a result of exercise training 
in patients with obstructive lung disease. Am Rev Respir 
Dis 1991; 143: 9-18. 
1198 D. K. KIRSTEN ET AL. 
19. 
20. 
21. 
22. 
O’Donnell DE, Webb KA. Exertional breathlessness in 
patients with chronic airflow limitation. The role of 
lung hyperinflation. Am Rev Respir Dis 1993; 148: 
1351-1357. 
Redelmeier FA, Bayoumi AM, Goldstein RS, Guyatt 
GH. Interpreting small differences in functional status: 
the six minute walk test in chronic lung disease patients. 
Am J Respir Crit Care Med 1997; 155: 12781282. 
Knox AJ, Morrison JFJ, Muers MF. Reproducibility 
of walking test results in chronic obstructive airway 
disease. Thorax 1988; 43: 388-392. 
Belman MJ, Epstein LJ, Doornbos D, Elashoff JD, 
Koerner SK Mohsenifar Z. Noninvasive determina- 
tions of the aerobic threshold. Reliability and validity 
in patients with COPD. Chest 1992; 102: 102881034. 
23. 
24. 
25. 
26 
’ 
Kanarek D, Kaplan D, Kazemi H. The anaerobic 
threshold in severe chronic obstructive lung disease. 
Bull Eur Physiopath Resp 1979; 15: 163-169. 
LoRusso TJ, Belman MJ, Elashoff JD, Koerner SK. 
Prediction of maximal exercise capacity in obstructive 
and restrictive pulmonary disease. Chest 1993; 104: 
1748-1754. 
Carter R, Nicotra B, Clark L, Zinkgraf S, Williams J, 
Peavler M, Fields S, Berry J. Exercise conditioning in 
the rehabilitation of patients with chronic obstructive 
pulmonary disease. Arch Phys Med Rehabil 1988; 69: 
118-122. 
Belman MJ. Exercise in patients with chronic obstruc- 
tive pulmonary disease. Thorax 1993; 48: 936-946. 
